IQV
IQVIA HOLDINGS INC.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$267.33
−2.81%Price chart
Oct 1Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30
Key dataOct 30, 2026
Open$273.06
From 52W high−4.31%
Volume1.14M
Market cap$44.06B
P/E (TTM)32.1x
P/S (TTM)2.5x
Div yield—
Key dataOct 30, 2026
Open
$273.06
From 52W high
−4.31%
Volume
1.14M
Market cap
$44.06B
ValuationView details →
P/E (Fwd)
19.3x
EV/EBITDA
16.1x
P/E (TTM)
32.1x
RSI (14)
48.3
MomentumView details →
1D Return
−2.81%
YTD Return
+18.24%
SummaryUpdated Sep 1, 2026
IQVIA Holdings Inc. (NASDAQ:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Founded in 1982 and originally known as Quintiles IMS Holdings, the company changed its name to IQVIA in November 2017. Headquartered in Durham, North Carolina, IQVIA was formed through the merger of Quintiles (a clinical research organization) and IMS Health (a healthcare data and analytics company). Today, the company operates across the Americas, Europe, Africa, and the Asia-Pacific region, serving pharmaceutical, biotechnology, device and diagnostic, and consumer health companies worldwide.
Similar companies
Latest newsMore news →
IQVIA HOLDINGS INC. reported third-quarter 2026 revenue of $4.428 billion, up 8% year over year, and net income of $350 million; it also provided full-year 2026 guidance.3d agoIQVIA HOLDINGS INC. reported quarterly earnings of $3.34 per share, above the Zacks Investment Research, Inc. Consensus Estimate of $3.24 and compared with $3 per share a year earlier.4d agoIQVIA HOLDINGS INC. and VEEVA SYSTEMS INC announced an extension of their partnership, with IQVIA HOLDINGS INC. selecting Veeva CTMS and eTMF applications.18d ago